← Back to Search

Omega-3 Fatty Acids

Omega-3 Fatty Acids for Sickle Cell Disease

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 weeks

Awards & highlights

Study Summary

This trial aims to study if plant-based omega-3-fatty acids can reduce pain and improve outcomes in people with sickle cell disease.

Who is the study for?

This trial is for children and teenagers aged 5-18 with sickle cell anemia (HbSS or HbSB0 thal) who are not on chronic transfusion therapy, not taking pre/probiotic supplements, antibiotics, PPIs, and aren't pregnant or breastfeeding. They should also have no known allergy to plant-based omega-3 fatty acids.Check my eligibility

What is being tested?

The study tests if plant-based omega-3 fatty acids can be a more acceptable treatment option for SCD patients and improve their outcomes by reducing inflammation-related pain compared to fish oil-derived omega-3s.See study design

What are the potential side effects?

While the trial's description doesn't specify side effects of plant-based omega-3s, typical ones may include mild digestive issues or allergic reactions in those sensitive to the ingredients.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acute pain

Chronic pain

Secondary outcome measures

Inflammation

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Plant based omega 3 Fatty AcidExperimental Treatment1 Intervention

Participants ingest their regular diet supplemented with a plant-based omega-3-FA

Group II: Regular dietActive Control1 Intervention

Participants will continue their regular diet.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor

1,590 Previous Clinical Trials

2,281,632 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants has this clinical trial enrolled?

"Affirmative. Data on clinicaltrials.gov shows the this medical study, which was originally posted on August 30th 2023, is actively seeking volunteers. Approximately 30 patients must be recruited from 1 specialized facility."

Answered by AI

Are senior citizens being accepted into the trial?

"To qualify for this clinical trial, patients must be between 5 and 18 years of age. According to our records there are 119 trials underway targeting minors while 79 target those aged 65 or older."

Answered by AI

Are there any open slots available for this experiment?

"Affirmative, the information hosted on clinicaltrials.gov indicates that this medical trial is actively searching for participants. It was initially published on August 30th 2023 and has been modified since then; its aim to recruit a total of 30 patients from one single centre."

Answered by AI

What criteria must individuals meet to participate in this research?

"To be eligible for the trial, potential participants must have sickle cell disease and an age between 5-18 years old. 30 individuals in total can join this clinical study."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell Disease

Chinenye Dike 2023. "Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05758766.

All > Sickle Cell Disease